SCHEMBL30906407

SCHEMBL30906407

CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 14/20 0.58
▸ GIPR P48546 14/20 0.58
▸ KISS1R Q969F8 4/20 0.58
▸ GALR2 O43603 1/20 0.57
▸ GALR1 P47211 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30906418 0.97 NPY1R (0.57) GLP1RGIPRKISS1RGALR2GALR1
SCHEMBL30906342 0.94 CAPN1 (0.53) GLP1RGIPR
SCHEMBL30906445 0.91 GLP1R (0.63) GLP1R
SCHEMBL30906405 0.90 GLP1R (0.62) GLP1R
SCHEMBL30906357 0.90 NPY1R (0.57) GLP1RGIPRGALR2GALR1
SCHEMBL30906544 0.89 GLP1R (0.62) GLP1R
SCHEMBL30906332 0.89 GLP1R (0.55) GLP1RGIPRKISS1RGALR2GALR1
SCHEMBL30906540 0.88 NPY1R (0.55) GLP1RGIPR
SCHEMBL30906505 0.88 NPY1R (0.58) GLP1RGIPR
SCHEMBL30906348 0.87 NPY1R (0.51) GLP1RGIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598964-A2 ANTI-IGE ANTIBODIES Abwiz Bio, Inc. (US) 2025-08-13 — — EP disclosed
US-20240182599-A1 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. 2024-06-06 — — US disclosed
WO-2024076785-A2 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. (US) 2024-04-11 — — WO disclosed
Send feedback